Methyl 3-amino-2-[2-[2-methyl-7-(N-methylanilino)indazol-3-yl]ethynyl]pyridine-4-carboxylate
C24H21N5O2 — CID 118973821
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 3-amino-2-[2-[2-methyl-7-(N-methylanilino)indazol-3-yl]ethynyl]pyridine-4-carboxylate
Methyl 3-amino-2-[2-[2-methyl-7-(N-methylanilino)indazol-3-yl]ethynyl]pyridine-4-carboxylate (PubChem CID 118973821) has the molecular formula C24H21N5O2 and a molecular weight of 411.47 g/mol. Its IUPAC name is methyl 3-amino-2-[2-[2-methyl-7-(N-methylanilino)indazol-3-yl]ethynyl]pyridine-4-carboxylate.
Molecular Properties
| Compound Name | Methyl 3-amino-2-[2-[2-methyl-7-(N-methylanilino)indazol-3-yl]ethynyl]pyridine-4-carboxylate |
|---|---|
| PubChem CID | 118973821 |
| Molecular Formula | C24H21N5O2 |
| Molecular Weight | 411.47 g/mol |
| Exact Mass | 411.17 |
| IUPAC Name | methyl 3-amino-2-[2-[2-methyl-7-(N-methylanilino)indazol-3-yl]ethynyl]pyridine-4-carboxylate |
| SMILES | COC(=O)c1ccnc(C#Cc2c3cccc(N(C)c4ccccc4)c3nn2C)c1N |
| InChI | InChI=1S/C24H21N5O2/c1-28(16-8-5-4-6-9-16)21-11-7-10-17-20(29(2)27-23(17)21)13-12-19-22(25)18(14-15-26-19)24(30)31-3/h4-11,14-15H,25H2,1-3H3 |
| InChIKey | KHDTVCARFJKQBW-UHFFFAOYSA-N |
| XLogP | 3.50 |
| TPSA | 86.27 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 411.47 |
| LogP ≤ 5 | 3.50 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118973821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.